Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MAGE family member B6B (MAGEB6B), also referred to by several aliases, is encoded by a protein-coding gene. It is predicted to be involved in negative regulation of transcription by RNA polymerase II and presumed to function within the nucleus. The gene is associated with diseases such as hypopharynx cancer and retinitis pigmentosa 6, but direct evidence of therapeutic targeting or drug interactions is lacking. Notably, several aliases indicate the gene may represent a pseudogene, further supporting that it is likely not a classical drug target or receptor[1][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MAGE family member B6B (MAGEB6B).